Skip to main content
Erschienen in: Journal of Cancer Education 2/2021

09.11.2019

An Assessment of Cancer Education Needs to Promote Mid-Adult HPV Vaccination Among Male Sexual Minorities

verfasst von: Christopher W. Wheldon, Sarah B. Maness

Erschienen in: Journal of Cancer Education | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to assess behavioral expectations and related psychosocial factors regarding an age-expanded human papillomavirus (HPV) vaccine schedule among male sexual minorities (MSM). A measure of behavioral expectation (BE) (“How likely are you to get the HPV vaccine if the CDC recommendation was changed to include men older than 26?”) was evaluated on an ethnoracially diverse sample (N = 318) of MSM. Sixty-seven percent would likely initiate vaccination if the recommendations change. Benefits of HPV vaccination were widely endorsed. Barriers/harms of vaccination were endorsed less frequently. Only 15.4% were concerned that the vaccine would not be effective. The main driver of BE was perceived physical benefits (R2 = 0.34). Psychological benefits were independently associated with BE but did not improve the explanatory model. Expectation of HPV vaccination is high among MSM in the expanded age range. Prevention of anogenital warts and anal cancer is an important consideration for this population; however, promoting the benefits of vaccination must be done in accordance with realistic expectations of vaccine efficacy in older sexually active MSM.
Literatur
1.
Zurück zum Zitat Machalek D, Grulich AE, Jin Fengyi J et al (2012) The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health 9:527–537CrossRef Machalek D, Grulich AE, Jin Fengyi J et al (2012) The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health 9:527–537CrossRef
2.
Zurück zum Zitat Daling JR, Weiss NS, Hislop TG et al (1987) Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 317:973–977CrossRef Daling JR, Weiss NS, Hislop TG et al (1987) Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 317:973–977CrossRef
3.
Zurück zum Zitat Centers for Disease Control and Prevention (2011) Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 60:1705–1708 Centers for Disease Control and Prevention (2011) Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 60:1705–1708
4.
Zurück zum Zitat Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019) Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 68:698–702CrossRef Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019) Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 68:698–702CrossRef
7.
Zurück zum Zitat Wheldon CW, Sutton SK, Fontenot HB, Quinn GP, Giuliano AR, Vadaparampil ST (2018) Physician communication practices as a barrier to risk-based HPV vaccine uptake among men who have sex with men. J Cancer Educ 33:1126–1131CrossRef Wheldon CW, Sutton SK, Fontenot HB, Quinn GP, Giuliano AR, Vadaparampil ST (2018) Physician communication practices as a barrier to risk-based HPV vaccine uptake among men who have sex with men. J Cancer Educ 33:1126–1131CrossRef
10.
Zurück zum Zitat Wheldon CW, Daley EM, Buhi ER et al (2015) HPV vaccine decision-making among young gay and bisexual men. Health Educ J 76:1–14 Wheldon CW, Daley EM, Buhi ER et al (2015) HPV vaccine decision-making among young gay and bisexual men. Health Educ J 76:1–14
12.
Zurück zum Zitat Wheldon CW, Daley EM, Walsh-Buhi ER, Baldwin JA, Nyitray AG, Giuliano AR (2018) An integrative theoretical framework for HPV vaccine promotion among male sexual minorities. Am J Mens Health 12:1409–1420CrossRef Wheldon CW, Daley EM, Walsh-Buhi ER, Baldwin JA, Nyitray AG, Giuliano AR (2018) An integrative theoretical framework for HPV vaccine promotion among male sexual minorities. Am J Mens Health 12:1409–1420CrossRef
13.
Zurück zum Zitat Warshaw PR, Davis FD (1985) Disentangling behavioral intention and behavioral expectation. J Exp Soc Psychol 21:213–228CrossRef Warshaw PR, Davis FD (1985) Disentangling behavioral intention and behavioral expectation. J Exp Soc Psychol 21:213–228CrossRef
15.
Zurück zum Zitat Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD (2014) Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect 90:515–523CrossRef Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD (2014) Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect 90:515–523CrossRef
Metadaten
Titel
An Assessment of Cancer Education Needs to Promote Mid-Adult HPV Vaccination Among Male Sexual Minorities
verfasst von
Christopher W. Wheldon
Sarah B. Maness
Publikationsdatum
09.11.2019
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2021
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01644-w

Weitere Artikel der Ausgabe 2/2021

Journal of Cancer Education 2/2021 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.